Electrophysiological signatures of inhibitory control in children with Tourette syndrome and attention-deficit/hyperactivity disorder

Cortex ◽  
2021 ◽  
Author(s):  
Simon Morand-Beaulieu ◽  
Stephanie D. Smith ◽  
Karim Ibrahim ◽  
Jia Wu ◽  
James F. Leckman ◽  
...  
CNS Spectrums ◽  
2008 ◽  
Vol 13 (4) ◽  
pp. 301-303 ◽  
Author(s):  
Jessica Sears ◽  
Nitin C. Patel

ABSTRACTTics and Tourette syndrome are common comorbidities of patients diagnosed with attention-deficit/hyperactivity disorder (ADHD). One of the mainstay pharmacologic therapies for ADHD has been stimulants. However, this class of drugs has been associated with tic exacerbations, thus limiting their utility in this patients subgroup. Atomoxetine has been explored as an alternative treatment as one of the few non-stimulants available to treat ADHD. Early data identifies atomoxetine's influence on Tourette symptomatology to be not merely equivocal but potentially suppressive in the manifestation of tics. There are, however, case studies describing patients experiencing recurrences of tics following treatment with atomoxetine. We present a unique case of a patient, without any prior history of a movement disorder, who developed tics following a single dose of atomoxetine that did not improve until interventional therapy was initiated.


2019 ◽  
Vol 292 ◽  
pp. 13-22
Author(s):  
Sophie E.A. Akkermans ◽  
Daan van Rooij ◽  
Jilly Naaijen ◽  
Natalie J. Forde ◽  
Regina Boecker-Schlier ◽  
...  

1997 ◽  
Vol 12 (7) ◽  
pp. 438-442 ◽  
Author(s):  
Linda J. Schuerholz ◽  
Laurie Cutting ◽  
Michele M. M. Mazzocco ◽  
Harvey S. Singer ◽  
Martha B. Denckla

Sign in / Sign up

Export Citation Format

Share Document